Overexpression of fibroblast growth factor receptor 3 (FGFR3) has been shown to drive oncogenesis in a subset of patients with multiple myeloma. However, epithelial cancers - such as bladder cancer - also exhibit deregulation and mutation of FGFR3, but whether this contributes to tumorigenesis in vivo has remained unclear.
展开▼
